Related Experiment Video
Updated: Jul 17, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Inhibition of GSK3 promotes replication and survival of pancreatic beta cells
Rainer Mussmann1, Marcus Geese, Friedrich Harder
1DeveloGen AG, Marie-Curie-Strasse 7, Göttingen 37079, Germany.
Abstract:
Recent developments indicate that the regeneration of beta cell function and mass in patients with diabetes is possible. A regenerative approach may represent an alternative treatment option relative to current diabetes therapies that fail to provide optimal glycemic control. Here we report that the inactivation of GSK3 by small molecule inhibitors or RNA interference stimulates replication of INS-1E rat insulinoma cells. Specific and potent GSK3 inhibitors also alleviate the toxic effects of high concentrations of glucose and the saturated fatty acid palmitate on INS-1E cells. Furthermore, treatment of isolated rat islets with structurally diverse small molecule GSK3 inhibitors increases the rate beta cell replication by 2-3-fold relative to controls. We propose that GSK3 is a regulator of beta cell replication and survival. Moreover, our results suggest that specific inhibitors of GSK3 may have practical applications in beta cell regenerative therapies.
Insights
Glycogen synthase kinase 3 (GSK3) inhibition promotes beta cell replication and survival. This suggests GSK3 inhibitors could be a novel therapy for diabetes, improving beta cell regeneration.
Area of Science:
- Endocrinology
- Cell Biology
- Regenerative Medicine
Background:
- Current diabetes therapies often fail to achieve optimal glycemic control.
- Beta cell regeneration offers a potential alternative treatment strategy.
- The role of Glycogen Synthase Kinase 3 (GSK3) in beta cell function is under investigation.
Purpose of the Study:
- To investigate the role of GSK3 in beta cell replication and survival.
- To evaluate the potential of GSK3 inhibitors as a therapeutic approach for diabetes.
Main Methods:
- Inactivation of GSK3 in INS-1E rat insulinoma cells using small molecule inhibitors and RNA interference.
- Assessment of beta cell toxicity under high glucose and palmitate conditions.
- Treatment of isolated rat islets with diverse GSK3 inhibitors to measure beta cell replication rates.
Main Results:
- GSK3 inactivation stimulated INS-1E cell replication.
- Specific GSK3 inhibitors protected INS-1E cells from glucose and palmitate toxicity.
- Treatment with GSK3 inhibitors increased beta cell replication in isolated rat islets by 2-3 fold.
Conclusions:
- GSK3 is identified as a key regulator of beta cell replication and survival.
- GSK3 inhibitors demonstrate potential for beta cell regenerative therapies.
- Targeting GSK3 may offer a novel strategy for managing diabetes.
More Related Videos
07:44Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
Published on: August 7, 2015
06:57Intramuscular Transplantation of Human Pluripotent Stem Cell-derived Pancreatic Endocrine Cells in Mice
Published on: April 10, 2026
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Cell Specific Gene Expression
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Dipeptidyl Peptidase 4 Inhibitors
Insulin Secretory Vesicles
Inhibition of Cdk Activity